Form 4: AMWL Officer Sells Shares Under 10b5-1 Plan

American Well Corp's Chief Product & Tech. Officer, Dmitry Zamansky, sold 2,472 shares of Class A Common Stock for $5.45 per share under a pre-arranged trading plan.

Summary

• Dmitry Zamansky, Chief Product & Tech. Officer of American Well Corp, sold 2,472 shares of Class A Common Stock.
• The sale occurred on March 2, 2026, at a price of $5.45 per share.
• This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on December 1, 2025.
• Following the sale, Zamansky beneficially owns 196,242 shares of Class A Common Stock.
• The beneficially owned shares include those acquired through the company's employee stock purchase plan, which are exempt under Rule 16b-3.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. Insider sales under a 10b5-1 plan are typically pre-scheduled and do not necessarily reflect a change in management's outlook on the company.

Industry Context

StockSavvy.ai notes that insider sales executed under a Rule 10b5-1 plan are generally considered less indicative of management's sentiment about the company's future prospects compared to open market sales, as these plans are pre-scheduled and adopted when the insider is not in possession of material non-public information. Such transactions are a common part of executive compensation and personal financial planning.

Comparison to Industry Standards

• This is a routine insider transaction, common across all industries for executives managing their equity compensation. There are no specific comparable companies or projects to benchmark against for this type of filing, as it reflects an individual's personal financial planning rather than company performance.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, pre-scheduled insider sale, not indicative of new material information.

Key Dates

Recommendation

This Form 4 reports a routine insider sale under a pre-arranged 10b5-1 trading plan. Such transactions are common for executives managing personal finances and are generally not considered a strong signal for future stock performance. The relatively small number of shares sold compared to the officer's remaining holdings suggests no immediate change in investment thesis is warranted based solely on this filing.

Keywords

American Well Corp, AMWL, Dmitry Zamansky, Insider Sale, Form 4, 10b5-1 Plan, Stock Transaction, Chief Product & Tech. Officer, Equity Sales